SEC Form 4 · accession 0001209191-15-031737
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryuji Ueno
10% Owner
Period of report
Mar 31, 2015
Accepted (ET)
Apr 2, 2015 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Mar 31, 2015 | S | 353,530 | $14.00 | D | 0 | D | |
| Class A Common StockF2 | Mar 31, 2015 | S | 60,357 | $14.00 | D | 0 | I | By Wife |
| Class A Common StockF3 | Mar 31, 2015 | S | 1,186,113 | $14.00 | D | 20,274,689 | I | By S&R Technology Holdings, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected as part of an underwritten public offering in which the reporting person, his wife and S&R Technology Holdings, LLC each participated as a selling stockholder.
- F2Dr. Ueno disclaims beneficial ownership of the reported securities.
- F3S&R Technology Holdings, LLC is wholly owned by Dr. Ueno and his wife. Dr. Ueno disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.